John B. Craig
Impact in
- Toxicology top 10%
-
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
-
- Cancer therapeutics and mechanisms 7
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Bayard L. Powell (9 shared papers)John G. Kuhn (8 shared papers)A Oliff (1 shared paper)D. Martínez (1 shared paper)Susan H. Socher (1 shared paper)Hyman B. Muss (4 shared papers)Vinay K. Malviya (2 shared papers)P. Y. Liu (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Investigational New Drugs (4 papers)Anti-Cancer Drugs (4 papers)The American Journal of the Medical Sciences (2 papers)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesJapanMyanmar
In The Last Decade
John B. Craig
26 papers receiving 513 citations
Peers
Comparison fields: 5 of 97
- Toxicology 22
- Oncology 155
- Pulmonary and Respiratory Medicine 94
- Physiology 74
- Surgery 120
Countries citing papers authored by John B. Craig
This map shows the geographic impact of John B. Craig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Craig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Craig more than expected).
Fields of papers citing papers by John B. Craig
This network shows the impact of papers produced by John B. Craig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Craig. The network helps show where John B. Craig may publish in the future.
Co-authors
The 25 scholars most cited alongside John B. Craig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 109 | |
| 2 | 1987 | 72 | |
| 3 | 1984 | 60 | |
| 4 | 1985 | 58 | |
| 5 | 1992 | 53 | |
| 6 | 1989 | 34 | |
| 7 | 1995 | 34 | |
| 8 | 1991 | 20 | |
| 9 | 1994 | 16 | |
| 10 | Phase I and clinical pharmacology trial of crisnatol (BWA770U mesylate) using a monthly single-dose schedule. | 1988 | 12 |
| 11 | 1994 | 9 | |
| 12 | 1991 | 7 | |
| 13 | Deoxyspergualin: phase I clinical, immunologic and pharmacokinetic study. | 1995 | 7 |
| 14 | The relationship between the emotional intelligence of the principal and teacher job satisfaction | 2008 | 7 |
| 15 | 1988 | 6 | |
| 16 | Phase I clinical trial of carbetimer. | 1988 | 6 |
| 17 | 1993 | 5 | |
| 18 | 1995 | 5 | |
| 19 | 1988 | 3 | |
| 20 | 1993 | 3 |
About John B. Craig
John B. Craig is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Hematology, having authored 28 papers that have together received 538 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers), Nausea and vomiting management (2 papers), Glycosylation and Glycoproteins Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Toxicology (22 citations), Oncology (155 citations), Pulmonary and Respiratory Medicine (94 citations), Physiology (74 citations) and Surgery (120 citations). John B. Craig has collaborated with scholars based in United States, Japan and Myanmar. Frequent co-authors include Bayard L. Powell, John G. Kuhn, A Oliff, D. Martínez, Susan H. Socher, Hyman B. Muss, Vinay K. Malviya, P. Y. Liu, Earl A. Surwit and David S. Alberts. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Anti-Cancer Drugs, The American Journal of the Medical Sciences and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.